Coya Therapeutics, Inc. (COYA) Form 424B5 — May 12, 2026
Coya Therapeutics, Inc. has entered into a Sales Agreement with Leerink Partners LLC to offer up to $30,000,000 in common stock through an at-the-market offering. The offering price is based on the last reported sale price of $4.11 per share on The Nasdaq Capital Market on May 8, 2026. Leerink Partners will act as the sales agent, using commercially reasonable efforts to sell the shares on behalf of Coya Therapeutics.
Key figures
- Gross Proceeds
- 30,000,000
- Offering Price
- 4.11
- Shares Offered
- 7,299,270
Price after filing
1 day: +5.8%7 days: +6.5%30 days: +2.8%
Close on the filing date to close N calendar days later (from $4.29). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.